A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder
Clinical trial NCT06951698 · RECRUITING
Trial details
- NCT number
- NCT06951698
- Sponsor
- Bristol-Myers Squibb
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-11
- Primary completion
- 2026-11-01
- Enrollment
- 274
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.